LASHAUN MCDOWELL-ESAW: Open Payments
NPI 1548041031 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,628 in 68 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $417 · 2025 $1,628
Food & beverage: $1,628
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $314 |
| Lilly USA, LLC | 7 | $307 |
| AstraZeneca Pharmaceuticals LP | 4 | $201 |
| Xeris Pharmaceuticals, Inc. | 7 | $146 |
| Amgen Inc. | 13 | $137 |
| PFIZER INC. | 5 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| SANOFI-AVENTIS U.S. LLC | 2 | $74 |
| ABBVIE INC. | 3 | $72 |
| GlaxoSmithKline, LLC. | 3 | $44 |
Products named: ZEPBOUND, Ozempic, AIRSUPRA, RECORLEV, OTEZLA, ELIQUIS, CAPLYTA, TZIELD.
Industry payments across FL — which companies pay providers there.
